Researchers suggest targeting mTOR activity in aggressive cancers by blocking cholesterol sensing may represent a promising ...
While many American adults are trying to reduce cholesterol levels, certain cancerous tumors have a relentless appetite for ...
Kinases that shuttle cholesterol within tumor cells help fuel growth. Blocking these enzymes may starve cancer cells, ...
While many American adults are trying to reduce cholesterol levels, certain cancerous tumors have a relentless appetite for ...
While many American adults are trying to reduce cholesterol levels, certain cancerous tumors have a relentless appetite for the metabolite. Some tumor ...
Adding the experimental inhaled therapy LAM-001 to ongoing treatment for PH-ILD may help reduce symptoms in a clinically ...
Muscles age differently than you think. Discover the science behind the aging muscle paradox—and how exercise can help you ...
Hyundai Motor Group showcases its hydrogen ecosystem vision for Europe at the World Hydrogen Summit 2026 in Rotterdam; The ...
The protein kinase mammalian or mechanistic target of rapamycin (mTOR) is an atypical serine/threonine kinase that exerts its main cellular functions by interacting with specific adaptor proteins to ...
Study reveals how Golgi proteins GOLPH3 and MYO18A route RTKs to the cell surface, setting oncogenic signaling strength and ...
Celcuity (CELC) stock: gedatolisib Phase 3 VIKTORIA-1 PFS gains in HR+/HER2- breast cancer, runway to 2027 and valuation ...
Clinically significant angiokeratomas represent a rare, chronic and debilitating lymphatic malformation with no FDA-approved therapies and an estimated more than 50,000 diagnosed patients in the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results